Holen Sie sich die Stockscreener-App
6.00
11.11%
0.60
Handel nachbörslich:
6.05
0.05
+0.83%
Schlusskurs vom Vortag:
$5.40
Offen:
$5.35
24-Stunden-Volumen:
9.77M
Relative Volume:
1.67
Marktkapitalisierung:
$1.29B
Einnahmen:
$2.59M
Nettoeinkommen (Verlust:
$-137.89M
KGV:
-7.4074
EPS:
-0.81
Netto-Cashflow:
$-69.76M
1W Leistung:
+8.30%
1M Leistung:
+29.59%
6M Leistung:
+334.78%
1J Leistung:
+445.45%
1-Tages-Spanne:
$5.34
$6.2399
1-Wochen-Bereich:
$5.06
$6.2399
52-Wochen-Spanne:
$1.04
$6.2399
Atai Life Sciences N V Stock (ATAI) Company Profile
Firmenname
Atai Life Sciences N V
Sektor
Branche
Telefon
49 89 2153 9035
Adresse
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Vergleichen Sie ATAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATAI
Atai Life Sciences N V
|
6.00 | 1.19B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-29 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-18 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-03 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
| 2021-11-11 | Eingeleitet | ROTH Capital | Buy |
| 2021-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-01 | Eingeleitet | Jefferies | Buy |
| 2021-07-13 | Eingeleitet | Berenberg | Buy |
| 2021-07-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-13 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-07-13 | Eingeleitet | Cowen | Outperform |
| 2021-07-13 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Atai Life Sciences N V Aktie (ATAI) Neueste Nachrichten
How institutional ownership impacts Atai Life Sciences N.V. stockQuarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside - Sahm
Atai Life Sciences N.V. stock chart pattern explainedQuarterly Market Summary & Low Risk High Reward Trade Ideas - newser.com
Quantitative breakdown of Atai Life Sciences N.V. recent moveJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - newser.com
Can Atai Life Sciences N.V. stock resist sector downturnsJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
Ranking Atai Life Sciences N.V. among high performing stocks via toolsJuly 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com
How Atai Life Sciences N.V. (9VC) stock responds to job market shiftsGold Moves & Short-Term Trading Alerts - newser.com
How high can Atai Life Sciences N.V. stock goJuly 2025 Recap & Safe Investment Capital Preservation Plans - newser.com
Is now a turning point for Atai Life Sciences N.V.Profit Target & Verified Swing Trading Watchlists - newser.com
Can swing trading help recover from Atai Life Sciences N.V. losses2025 Top Gainers & High Conviction Investment Ideas - newser.com
Combining machine learning predictions for Atai Life Sciences N.V.Weekly Profit Analysis & Consistent Return Investment Signals - newser.com
Needham Initiates ATAI Life Sciences N.V at Buy With $12 Price Target - MarketScreener
Needham Initiates Coverage of Atai Life Sciences N.V. (ATAI) with Buy Recommendation - Nasdaq
ATAI Life Sciences files update on Beckley Psytech acquisition plans By Investing.com - Investing.com Nigeria
ATAI Life Sciences files update on Beckley Psytech acquisition plans - Investing.com
ATAI Life Sciences to Acquire Beckley Psytech - TipRanks
ATAI Life Sciences N.V. Announces Acquisition of Beckley Psytech - TradingView
Published on: 2025-10-10 04:54:45 - newser.com
Can technical indicators confirm Atai Life Sciences N.V.’s reversal2025 Growth vs Value & Weekly Market Pulse Updates - newser.com
ATAI Life Sciences N.V. (ATAI) Stock Analysis: A Biotech Gem With 107% Potential Upside - DirectorsTalk Interviews
Atai Life Sciences N.V. stock retracement – recovery analysisWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com
Can trapped investors hope for a rebound in Atai Life Sciences N.V.Portfolio Growth Summary & Low Risk Growth Stock Ideas - newser.com
What to expect from Atai Life Sciences N.V. in the next 30 daysJuly 2025 Selloffs & Technical Confirmation Trade Alerts - newser.com
Evaluating Atai Life Sciences N.V. with trendline analysis2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
What sentiment indicators say about Atai Life Sciences N.V. stockJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com
Will Atai Life Sciences N.V. stock outperform growth indexes2025 Market WrapUp & Safe Capital Growth Tips - newser.com
How to track smart money flows in Atai Life Sciences N.V.IPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Using RSI to spot recovery in Atai Life Sciences N.V.July 2025 Intraday Action & Expert Verified Movement Alerts - newser.com
Short interest data insights for Atai Life Sciences N.V.2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com
Momentum divergence signals in Atai Life Sciences N.V. chartPortfolio Growth Summary & Risk Managed Investment Signals - newser.com
Why Atai Life Sciences (ATAI) Is in Focus After Positive Depression Data and $239M Shelf Registration Filing - Yahoo Finance
What drives Atai Life Sciences NV stock priceMonthly Performance Summary & High Profit Trading Plans - earlytimes.in
Atai Life Sciences: Still A Decent ProspectBut Only Just (NASDAQ:ATAI) - Seeking Alpha
Atai Life Sciences files to sell 45.32M common shares by selling shareholders - MSN
ATAI Life Sciences files additional details on Beckley Psytech acquisition By Investing.com - Investing.com Australia
ATAI Life Sciences files additional details on Beckley Psytech acquisition - Investing.com India
ATAI Life Sciences to Acquire Beckley Psytech Shares - TipRanks
Finanzdaten der Atai Life Sciences N V-Aktie (ATAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):